Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
about
An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosisEffect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis.Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis.Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials.A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study."No evident disease activity": The use of combined assessments in the management of patients with multiple sclerosis.Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience.Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.Brain atrophy measurements should be used to guide therapy monitoring in MS - YES.Establishing pathological cut-offs for lateral ventricular volume expansion rates.
P2860
Q33697898-9C8CA0A7-8C65-4FB1-BC1F-DBFE5EE87DB8Q33868551-4176B6DE-D1AC-4D81-8CB4-605890C2E84BQ36293431-CC58789C-4ADF-4AB7-B11D-6C25C7B28FAFQ38630407-7FBBE26E-C0E2-4F69-A271-5732D440E365Q38659598-DDB64162-501F-466A-AB57-A0C2C6DEF994Q38808604-A571CCDC-993D-41B0-85F1-F9CC05076589Q41185260-F0FA3844-810F-43E7-9B7E-7C4BDBD90066Q47105088-F046F791-701E-436D-B46B-67BFCAEC8107Q47820950-47DA1DA4-FB0F-4435-BAE3-CB18450A0D16Q47967210-4966C21C-7BA5-4892-B1C4-3CEA15672FCCQ48660868-58FD7ADB-B17F-483A-AA70-E4D7677196DCQ52661563-8A8EA7D1-50DE-4341-B8B0-9D47F517C10B
P2860
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical relevance of brain at ...... its use in a clinical routine.
@ast
Clinical relevance of brain at ...... its use in a clinical routine.
@en
type
label
Clinical relevance of brain at ...... its use in a clinical routine.
@ast
Clinical relevance of brain at ...... its use in a clinical routine.
@en
prefLabel
Clinical relevance of brain at ...... its use in a clinical routine.
@ast
Clinical relevance of brain at ...... its use in a clinical routine.
@en
P2093
P2860
P50
P1476
Clinical relevance of brain at ...... its use in a clinical routine.
@en
P2093
Bianca Weinstock-Guttman
Manuela Vaneckova
Michael Barnett
Michael G Dwyer
Rahil Ahmed
Ralph R H Benedict
Robert Zivadinov
Sirin Gandhi
P2860
P304
P356
10.1080/14737175.2016.1181543
P577
2016-04-22T00:00:00Z